一、Hpd-激光诊疗法血卟啉衍生物(Hematoporphyrin derivative简称Hpd商品名photofrin),是血卟啉等的混合物,在50年代初美国Lipson等即报告它与癌组织有亲和性,1972年美国Dougherty报告用Hpd作为光敏剂治疗癌症,1976年开始临床试验。现已在中国、日本、意大利、加拿大,英国、西德、荷兰、挪威等国家少数单位中较为广泛地研究运 I. Hpd-laser therapy Hematoporphyrin derivative (abbreviated Hpd trade name photofrin) is a mixture of hematoporphyrins, etc. In the early 50’s, Lipson et al. reported that it had affinity with cancer tissues, 1972. Dougherty of the United States reported using Hpd as a photosensitizer to treat cancer and began clinical trials in 1976. It has been widely studied in a few units in China, Japan, Italy, Canada, the United Kingdom, West Germany, the Netherlands, Norway and other countries.